STOCK TITAN
  1. Home
  2. Sec-filings
  3. NTRA
  4. [Form 4] Natera, Inc. Insider Trading Activity

Natera (NTRA) co-founder’s family trusts sell 1,500 shares under 10b5-1 plan

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Natera, Inc. director and co-founder Jonathan Sheena reported indirect open-market sales of common stock by family trusts associated with him. The trusts sold a total of 1,500 shares on April 17, 2026 in two transactions at weighted average prices of about $199.59 and $199.66 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on June 7, 2024. The sales were executed by the Caraluna 1 and Caraluna 2 Trusts, which hold the shares for trust beneficiaries, and Sheena disclaims beneficial ownership of those securities. Following these transactions, the filing shows 259,255 Natera shares held directly by Sheena and 20,282 shares reported as held indirectly through each trust.

Positive

  • None.

Negative

  • None.
Insider Sheena Jonathan
Role Director
Sold 1,500 shs ($299K)
Type Security Shares Price Value
Sale Common Stock 750 $199.664 $150K
Sale Common Stock 750 $199.5906 $150K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 20,282 shares (Indirect, By Caraluna 1 Trust); Common Stock — 20,282 shares (Indirect, By Caraluna 2 Trust); Common Stock — 259,255 shares (Direct)
Footnotes (4)
  1. F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
  2. F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.1950 to $199.9750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
  4. F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.1950 to $199.9550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares sold 1,500 shares Total Natera common stock sold by Caraluna trusts on April 17, 2026
Sale price (Caraluna 2 Trust) $199.5906 per share Weighted average sale price for 750 shares on April 17, 2026
Sale price (Caraluna 1 Trust) $199.6640 per share Weighted average sale price for 750 shares on April 17, 2026
Direct holdings after 259,255 shares Natera common stock held directly by Jonathan Sheena after reported date
Indirect holdings per trust 20,282 shares Natera common stock reported as held by each Caraluna trust after sales
Rule 10b5-1 plan adoption date June 7, 2024 Date Sheena adopted the trading plan governing the April 17, 2026 sales
Rule 10b5-1 trading plan regulatory
"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The reported price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership over such securities."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
indirect ownership financial
"direct_or_indirect": "I", "nature_of_ownership": "By Caraluna 2 Trust""

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transactions did Natera (NTRA) disclose for Jonathan Sheena?
Natera director and co-founder Jonathan Sheena reported indirect sales of 1,500 shares of common stock. The trades were executed by the Caraluna 1 and Caraluna 2 Trusts on April 17, 2026 under a pre-arranged Rule 10b5-1 trading plan adopted in June 2024.

At what prices were the Natera (NTRA) shares sold in this Form 4?
The reported Natera share sales occurred at weighted average prices of about $199.5906 and $199.6640 per share. Footnotes state each price reflects multiple trades within narrow ranges around $199.20–$199.98, and detailed per-trade prices are available on written request.

How many Natera (NTRA) shares did the trusts sell and what remains?
The Caraluna 1 and Caraluna 2 Trusts together sold 1,500 Natera shares, 750 shares from each trust. After these sales, the Form 4 reports 20,282 shares held indirectly through each trust, in addition to Jonathan Sheena’s separately reported direct holdings.

Were the Natera (NTRA) insider sales made under a Rule 10b5-1 plan?
Yes. The filing states the trust share sales were effected under a Rule 10b5-1 trading plan adopted by Jonathan Sheena on June 7, 2024. Such plans pre-schedule trades, indicating the timing was set in advance rather than decided on the trade date.

Does Jonathan Sheena claim beneficial ownership of the trust-held Natera (NTRA) shares?
No. A footnote explains the trust shares are held for the benefit of the trusts’ beneficiaries, and Sheena disclaims beneficial ownership of those securities. The transactions are therefore attributed to the Caraluna 1 and Caraluna 2 Trusts rather than to him personally.

What are Jonathan Sheena’s direct Natera (NTRA) holdings after these transactions?
The Form 4 includes a holding line showing Jonathan Sheena directly owns 259,255 Natera common shares after the reported date. This direct position is separate from the 20,282 shares reported as held indirectly through each of the Caraluna trusts for their beneficiaries.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sheena Jonathan
(Last)(First)(Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
(Street)
AUSTIN TEXAS 78753
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)XOther (specify below)
CO-FOUNDER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/17/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock259,255D
Common Stock04/17/2026S750(1)D$199.664(2)20,282IBy Caraluna 1 Trust(3)
Common Stock04/17/2026S750(1)D$199.5906(4)20,282IBy Caraluna 2 Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.1950 to $199.9750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.1950 to $199.9550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Tami Chen, Attorney-in-Fact04/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR